NAGE vs. COR
NAGE (Niagen Bioscience, Inc) and COR (Cencora Inc.) are both stocks. Both are in the Healthcare sector — NAGE in Biotechnology, COR in Medical Distribution. Over the past 10 years, NAGE returned -4.75%/yr vs 16.59%/yr for COR. At a 0.08 correlation, their price movements are largely independent.
Performance
NAGE vs. COR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NAGE achieves a -44.34% return, which is significantly lower than COR's -21.27% return. Over the past 10 years, NAGE has underperformed COR with an annualized return of -4.75%, while COR has yielded a comparatively higher 16.59% annualized return.
NAGE
- 1D
- -1.94%
- 1M
- -27.01%
- YTD
- -44.34%
- 6M
- -44.69%
- 1Y
- -69.82%
- 3Y*
- 32.55%
- 5Y*
- -16.48%
- 10Y*
- -4.75%
COR
- 1D
- 0.06%
- 1M
- -12.68%
- YTD
- -21.27%
- 6M
- -24.17%
- 1Y
- -8.64%
- 3Y*
- 15.91%
- 5Y*
- 19.79%
- 10Y*
- 16.59%
NAGE vs. COR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NAGE Niagen Bioscience, Inc | -44.34% | 19.89% | 270.98% | -14.88% | -55.08% | -22.08% | 11.37% | 25.66% | -41.67% | 77.64% |
COR Cencora Inc. | -21.27% | 51.48% | 10.37% | 25.33% | 26.26% | 44.09% | 23.37% | 23.51% | -17.57% | 19.51% |
Correlation
The correlation between NAGE and COR is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.03 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.07 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Jul 16, 2008 | 0.08 |
The correlation between NAGE and COR shifts across timeframes, from 0.03 (3 years) to 0.14 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
NAGE:
$299.36M
COR:
$51.75B
NAGE:
$0.22
COR:
$13.07
NAGE:
16.23
COR:
20.26
NAGE:
0.14
COR:
9.63
NAGE:
2.32
COR:
0.16
NAGE:
3.64
COR:
15.23
NAGE:
$130.42M
COR:
$328.68B
NAGE:
$83.83M
COR:
$11.66B
NAGE:
$13.37M
COR:
$3.64B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NAGE vs. COR — Risk / Return Rank
NAGE
COR
NAGE vs. COR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Niagen Bioscience, Inc (NAGE) and Cencora Inc. (COR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NAGE | COR | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -1.34 | -0.29 | -1.05 |
Sortino ratioReturn per unit of downside risk | -2.47 | -0.17 | -2.29 |
Omega ratioGain probability vs. loss probability | 0.70 | 0.97 | -0.27 |
Calmar ratioReturn relative to maximum drawdown | -0.89 | -0.26 | -0.63 |
Martin ratioReturn relative to average drawdown | -1.29 | -0.78 | -0.51 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NAGE | COR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.34 | -0.29 | -1.05 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.21 | 0.89 | -1.11 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.06 | 0.61 | -0.67 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.03 | 0.54 | -0.57 |
Drawdowns
NAGE vs. COR - Drawdown Comparison
The maximum NAGE drawdown since its inception was -97.00%, which is greater than COR's maximum drawdown of -71.01%. Use the drawdown chart below to compare losses from any high point for NAGE and COR.
Loading charts...
Drawdown Indicators
| NAGE | COR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.00% | -71.01% | -25.99% |
Max Drawdown (1Y)Largest decline over 1 year | -75.43% | -32.44% | -42.99% |
Max Drawdown (3Y)Largest decline over 3 years | -75.43% | -32.44% | -42.99% |
Max Drawdown (5Y)Largest decline over 5 years | -88.71% | -32.44% | -56.27% |
Max Drawdown (10Y)Largest decline over 10 years | -93.65% | -32.44% | -61.21% |
Current DrawdownCurrent decline from peak | -81.11% | -29.04% | -52.07% |
Average DrawdownAverage peak-to-trough decline | -75.72% | -13.61% | -62.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 52.03% | 10.71% | +41.32% |
Volatility
NAGE vs. COR - Volatility Comparison
Niagen Bioscience, Inc (NAGE) and Cencora Inc. (COR) have volatilities of 20.89% and 20.44%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NAGE | COR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.89% | 20.44% | +0.45% |
Volatility (6M)Calculated over the trailing 6-month period | 34.44% | 27.22% | +7.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 52.93% | 30.04% | +22.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 77.23% | 22.31% | +54.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 80.03% | 27.47% | +52.56% |
Dividends
NAGE vs. COR - Dividend Comparison
NAGE has not paid dividends to shareholders, while COR's dividend yield for the trailing twelve months is around 0.89%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
COR Cencora Inc. | 0.89% | 0.67% | 0.93% | 0.96% | 1.13% | 5.13% | 6.74% | 7.48% | 2.07% | 1.61% | 1.77% | 1.17% |
NAGE Niagen Bioscience, Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
NAGE vs. COR - Financials Comparison
This section allows you to compare key financial metrics between Niagen Bioscience, Inc and Cencora Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NAGE vs. COR - Profitability Comparison
NAGE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Niagen Bioscience, Inc reported a gross profit of 19.98M and revenue of 31.47M. Therefore, the gross margin over that period was 63.5%.
COR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cencora Inc. reported a gross profit of 3.59B and revenue of 78.36B. Therefore, the gross margin over that period was 4.6%.
NAGE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Niagen Bioscience, Inc reported an operating income of 1.58M and revenue of 31.47M, resulting in an operating margin of 5.0%.
COR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cencora Inc. reported an operating income of 1.14B and revenue of 78.36B, resulting in an operating margin of 1.5%.
NAGE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Niagen Bioscience, Inc reported a net income of 6.32M and revenue of 31.47M, resulting in a net margin of 20.1%.
COR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cencora Inc. reported a net income of 1.64B and revenue of 78.36B, resulting in a net margin of 2.1%.
Frequently Asked Questions
NAGE and COR have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NAGE has higher volatility (20.89%) compared to COR (20.44%). In terms of maximum drawdown, NAGE dropped -97.00% vs COR's -71.01%.
COR currently has the higher Sharpe Ratio (-0.29 vs -1.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NAGE and COR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer